CO6700877A2 - Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo - Google Patents

Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo

Info

Publication number
CO6700877A2
CO6700877A2 CO13120944A CO13120944A CO6700877A2 CO 6700877 A2 CO6700877 A2 CO 6700877A2 CO 13120944 A CO13120944 A CO 13120944A CO 13120944 A CO13120944 A CO 13120944A CO 6700877 A2 CO6700877 A2 CO 6700877A2
Authority
CO
Colombia
Prior art keywords
diphenyl sulfide
sulfide derivative
pharmaceutical product
active ingredient
same
Prior art date
Application number
CO13120944A
Other languages
English (en)
Inventor
Kumi Ishikawa
Shigeru Koga
Yasushi Kohno
Kiyoshi Fujii
Ken Yoshikawa
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of CO6700877A2 publication Critical patent/CO6700877A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/664Amides of phosphorus acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids

Abstract

(Problema] Para proporcionar un derivado de difenil sulfuro que es útil como un producto farmacéutico que tiene excelente antagonista S1P3.(Solución] Los inventores han descubierto que un derivado de difenil sulfuro representado por general fórmula (1) (en donde R1 representa un grupo alcoxi que tiene 1-6 átomos de carbono, R2 representa un grupo propilo o un grupo alilo, X representa metileno o un átomo de oxígeno, y Z representa un átomo de halógeno) tiene excelente actividad antagonista S1P3 como un resultado de investigaciones extensivas para la producción de un compuesto que tiene actividad antagonista S1P3.
CO13120944A 2010-12-21 2013-05-16 Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo CO6700877A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010284150 2010-12-21

Publications (1)

Publication Number Publication Date
CO6700877A2 true CO6700877A2 (es) 2013-06-28

Family

ID=46313476

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13120944A CO6700877A2 (es) 2010-12-21 2013-05-16 Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo

Country Status (19)

Country Link
US (1) US8993543B2 (es)
EP (1) EP2657241B1 (es)
JP (1) JP5795333B2 (es)
KR (1) KR20140020240A (es)
CN (1) CN103261209B (es)
AU (1) AU2011346254B2 (es)
BR (1) BR112013015701A2 (es)
CA (1) CA2817688A1 (es)
CL (1) CL2013001329A1 (es)
CO (1) CO6700877A2 (es)
IL (1) IL226048A (es)
MX (1) MX2013005568A (es)
MY (1) MY161036A (es)
NZ (1) NZ610866A (es)
RU (1) RU2566296C2 (es)
SA (1) SA111330084B1 (es)
SG (1) SG190816A1 (es)
TW (1) TWI519539B (es)
WO (1) WO2012086184A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2015194157A1 (ja) * 2014-06-16 2017-04-20 杏林製薬株式会社 ジフェニルスルフィド誘導体の製造方法及び製造中間体
JPWO2016013225A1 (ja) * 2014-07-24 2017-04-27 杏林製薬株式会社 ジフェニルスルフィド誘導体の製造方法及び製造中間体

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1424078A4 (en) 2001-09-04 2009-03-25 Ono Pharmaceutical Co RESPIRATORY DISEASE MEDICINES COMPRISING A SPHINGOSINE-1-PHOSPHATE RECEPTOR REGULATING AGENT
JP4217620B2 (ja) 2001-09-27 2009-02-04 杏林製薬株式会社 ジアリールスルフィド誘導体とその付加塩及び免疫抑制剤
WO2003029184A1 (fr) 2001-09-27 2003-04-10 Kyorin Pharmaceutical Co., Ltd. Derive d'ether de diaryle, son sel d'addition et son immunosuppresseur
KR101003877B1 (ko) 2002-09-19 2010-12-30 교린 세이야꾸 가부시키 가이샤 아미노알코올 유도체와 그 부가염 및 면역 억제제
CN100344638C (zh) 2003-02-18 2007-10-24 杏林制药株式会社 氨基膦酸衍生物、其加成盐以及s1p受体调节剂
WO2005044478A2 (en) 2003-10-20 2005-05-19 International Resistive Company Resistive film on aluminum tube
JP2005247691A (ja) 2004-03-01 2005-09-15 Toa Eiyo Ltd S1p3受容体拮抗薬
MX2007006706A (es) 2004-12-06 2007-10-18 Univ Virginia Analogos de esfingosina 1-fosfato amida de arilo.
WO2007043568A1 (ja) 2005-10-12 2007-04-19 Toa Eiyo Ltd. S1p3受容体拮抗剤
WO2008019090A2 (en) 2006-08-04 2008-02-14 Praecis Pharmaceuticals Incorporated Agonists of the sphingosine-1-phosphate receptor
MY152176A (en) 2006-08-08 2014-08-15 Kyorin Seiyaku Kk Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
JP2010013407A (ja) * 2008-07-04 2010-01-21 Kyorin Pharmaceut Co Ltd アミノアルコール誘導体
JP2010077053A (ja) * 2008-09-25 2010-04-08 Kyorin Pharmaceut Co Ltd フェノール誘導体及びそれらを有効成分とする医薬
JP5616342B2 (ja) * 2009-07-09 2014-10-29 杏林製薬株式会社 ジフェニルスルフィド誘導体及びそれらを有効成分とする医薬
JP2011032226A (ja) * 2009-08-03 2011-02-17 Kyorin Pharmaceutical Co Ltd ジフェニルスルフィド誘導体及びそれらを有効成分とする医薬
SG185746A1 (en) * 2010-05-06 2013-01-30 Novartis Ag Treatment of autoimmune diseases
JP2013525469A (ja) * 2010-05-06 2013-06-20 ノバルティス アーゲー ジアリールスルフィド誘導体の投与レジメン

Also Published As

Publication number Publication date
CL2013001329A1 (es) 2014-02-07
MX2013005568A (es) 2013-08-26
RU2013133810A (ru) 2015-01-27
AU2011346254B2 (en) 2016-08-04
KR20140020240A (ko) 2014-02-18
EP2657241A4 (en) 2014-07-02
JP5795333B2 (ja) 2015-10-14
RU2566296C2 (ru) 2015-10-20
IL226048A (en) 2016-04-21
CN103261209B (zh) 2016-07-13
AU2011346254A1 (en) 2013-06-06
JPWO2012086184A1 (ja) 2014-05-22
US20130261089A1 (en) 2013-10-03
WO2012086184A1 (ja) 2012-06-28
NZ610866A (en) 2015-01-30
EP2657241A1 (en) 2013-10-30
SA111330084B1 (ar) 2014-07-02
BR112013015701A2 (pt) 2016-10-11
EP2657241B1 (en) 2017-07-12
CN103261209A (zh) 2013-08-21
CA2817688A1 (en) 2012-06-28
MY161036A (en) 2017-04-14
TW201307373A (zh) 2013-02-16
SG190816A1 (en) 2013-07-31
IL226048A0 (en) 2013-06-27
US8993543B2 (en) 2015-03-31
TWI519539B (zh) 2016-02-01

Similar Documents

Publication Publication Date Title
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
CY1123670T1 (el) Κρυσταλλικο παραγωγο 6,7-ακορεστης-7-καρβαμοϋλ μορφινανης, και μεθοδος για την παραγωγη αυτου
MA34006B1 (fr) Derives de dihydrofurane utilises comme composes insecticides
PH12015502232A1 (en) Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
RS53301B (en) TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES
EA201400247A1 (ru) Сельскохозяйственная и садоводческая фунгицидная композиция
RS54730B1 (sr) Inhibitori beta sekretaze
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
EA201270216A1 (ru) Фармацевтический состав
CO6531496A2 (es) Amidas sustituidas con halógenoalquilo como insecticidas y acaricidas
ECSP11011244A (es) Nuevos herbicidas.
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
EA201291376A1 (ru) Новые кальциевые соли соединения в качестве противовоспалительных, иммуномодулирующих и антипролиферативных агентов
GT201400167A (es) Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2
EA201490754A1 (ru) Производные карбамата/мочевины, содержащие пиперидиновые и пиперазиновые кольца, в качестве ингибиторов н3 рецептора
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
EA201491288A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ БРЕКСПИПРАЗОЛ И ЗАМЕЩЕННЫЙ β-ЦИКЛОДЕКСТРИН
EA201500605A1 (ru) Новые производные замещенного 1,4-дитиина и их применение в качестве фунгицидов
EA201600323A1 (ru) Производные пиперазина и их применение в качестве лекарственного средства
CO6700877A2 (es) Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo
MX2011010358A (es) Derivados de 2-hidroxietil-1h-quinolin-2-ona y sus analogos azaisostericos con actividad antibacteriana.
MX336430B (es) Derivados de dihidrofurano-azetadina como agentes antiparasitarios.
BR112013028368A2 (pt) novos compostos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona e octahidropiridinona

Legal Events

Date Code Title Description
FG Application granted